Combating hepatocellular carcinoma with an integrated approach

Area of Science:

• Hepatobiliary Surgery
• Interventional Radiology
• Medical Oncology

Background:

• Hepatocellular carcinoma (HCC) management requires innovative strategies.
• Chronic liver disease is a significant risk factor for HCC development.
• Early diagnosis and effective treatment are crucial for improving patient outcomes.

Purpose of the Study:

• To review an integrated approach for managing hepatocellular carcinoma (HCC).
• To highlight novel diagnostic and therapeutic methods for HCC.
• To present ongoing research and clinical trials for HCC treatment.

Main Methods:

• Detection of HCC-specific alpha-fetoprotein isoforms using isoelectric focusing for differential diagnosis.
• Phase I and II study of selective internal radiation therapy (SIRT) with yttrium-90 (90Y) microspheres for inoperable HCC.
• Development and clinical evaluation of a partition model for estimating radiation doses during 90Y microsphere therapy.
• Initiation of randomized controlled trials for adjuvant therapies, including iodine-131 Lipiodol.

Main Results:

• Alpha-fetoprotein isoforms show value in diagnosing early HCC in chronic liver disease patients.
• Yttrium-90 microsphere therapy is effective for inoperable HCC.
• The partition model allows safe administration of 90Y microspheres without open surgery.
• Ongoing trials aim to reduce HCC recurrence with adjuvant therapies.

Conclusions:

• An integrated approach combining novel diagnostics and therapies improves HCC management.
• Understanding HCC pathogenesis is key to combating the disease.
• Selective internal radiation therapy and adjuvant treatments show promise in clinical trials.